NCT00644839View on ClinicalTrials.gov

Study Examing The Effect Of Omeprazole On Safety, Tolerability And How The Body Processes An Experimental Drug

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Obesity
Interventions
DRUG

CP-945,598

Administration of CP-945,598 alone in period 1

DRUG

CP-945,598

Adminstration of CP-945,598 with omeprazole in period 2

Trial Locations (1)

33169

Pfizer Investigational Site, Miami

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY